$-0.22
(Market cap
$767 Mln
Revenue (TTM)
$0 Mln
P/E Ratio
--
P/B Ratio
2.5
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
$0 Mln
-
ROE
-0.5 %
-
ROCE
-- %
-
Industry P/E
--
-
EV/EBITDA
-5.7
-
Debt to Equity
0
-
Book Value
$--
-
EPS
$-1.8
-
Face value
--
-
Shares outstanding
103,704,809
5 Years Aggregate
CFO
$-195.85 Mln
EBITDA
$-223.91 Mln
Net Profit
$-214.47 Mln
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Aura Biosciences Inc (AURA)
| 31.7 | 1.0 | -3.9 | 14.7 | -12.2 | -- | -- |
|
BSE Sensex*
| -9.1 | -1.5 | 2.9 | -3.6 | 5.9 | 6.0 | 10.5 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
|---|---|---|---|---|
|
Aura Biosciences Inc (AURA)
| -33.7 | -7.2 | -15.6 | -38.2 |
|
S&P Small-Cap 600
| 4.0 | 7.0 | 13.9 | -17.4 |
|
BSE Sensex
| 9.1 | 8.1 | 18.7 | 4.4 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Aura Biosciences Inc (AURA)
|
7.2 | 767.4 | 0.0 | -131.0 | -- | -57.9 | -- | 2.5 |
| 82.4 | 11,993.9 | 669.5 | -320.0 | -0.8 | -71.1 | -- | 26.9 | |
| 70.9 | 10,022.2 | 71.0 | -894.0 | -1,175.8 | -- | -- | 60.3 | |
| 54.6 | 13,491.7 | 2,435.9 | 860.6 | 31.0 | 43 | 17.4 | 7.4 | |
| 106.5 | 11,957.0 | 1,663.7 | 413.6 | 36.3 | 430 | 30.9 | 84.5 | |
| 359.4 | 10,402.8 | 440.5 | 241.5 | 33.4 | 18.7 | 44.1 | 7.8 | |
| 540.0 | 12,332.1 | 1,283.9 | -325.1 | -19.0 | -57.7 | -- | 24.0 | |
| 594.0 | 16,765.1 | 2,782.3 | 491.5 | 21.1 | 110.1 | 35.2 | 39.3 | |
| 350.3 | 9,625.4 | 0.0 | -339.1 | -- | -30.6 | -- | 7.6 | |
| 147.8 | 9,339.4 | 282.0 | 82.9 | -28.6 | 11.4 | 140.1 | 11.5 |
Shareholding Pattern
View DetailsAbout Aura Biosciences Inc (AURA)
Aura Biosciences, Inc., a clinical-stage biotechnology company, develops precision therapies to treat solid tumors. The company's proprietary platform enables the targeting of a range of solid tumors using virus-like particles conjugated with drugs... or loaded with nucleic acids to create virus-like drug conjugates. Its lead candidate is bel-sar, which is in late-stage clinical development for the treatment of patients with primary choroidal melanoma and other ocular oncology indications, as well as in early-stage clinical development in bladder cancer. It focuses on assessing the safety and efficacy of bel-sar in treating a range of other solid tumors, including bladder cancer. The company was incorporated in 2009 and is headquartered in Boston, Massachusetts. Read more
-
Founder, CEO, President & Director
Dr. Elisabet de los Pinos Ph.D.
-
Founder, CEO, President & Director
Dr. Elisabet de los Pinos Ph.D.
-
Headquarters
Boston, MA
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for Aura Biosciences Inc (AURA)
What is the current share price of Aura Biosciences Inc (AURA) Today?
The share price of Aura Biosciences Inc (AURA) is $7.18 (NASDAQ) as of 31-Aug-2026 16:00 EDT. Aura Biosciences Inc (AURA) has given a return of -12.21% in the last 3 years.
What is the current PB & PE ratio of Aura Biosciences Inc (AURA)?
Since, TTM earnings of Aura Biosciences Inc (AURA) is negative, P/E ratio is not available.
The P/B ratio of Aura Biosciences Inc (AURA) is 2.53 times as on 28-Aug-2026, a 51 discount to its peers’ median range of 5.18 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
2025 |
-3.08 |
2.39 |
2024 |
-4.73 |
2.70 |
2023 |
-4.64 |
1.57 |
2022 |
-5.36 |
1.61 |
2021 |
-2.41 |
0.56 |
What is the 52 Week High and Low of Aura Biosciences Inc (AURA)?
The 52-week high and low of Aura Biosciences Inc (AURA) are Rs 9.54 and Rs 4.84 as of 01-Sep-2026.
What is the market cap of Aura Biosciences Inc (AURA)?
Aura Biosciences Inc (AURA) has a market capitalisation of $ 767 Mln as on 28-Aug-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Aura Biosciences Inc (AURA)?
Before investing in Aura Biosciences Inc (AURA), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.